TITLE

Identification and validation that up-expression of HOXA13 is a novel independent prognostic marker of a worse outcome in gastric cancer based on immunohistochemistry

AUTHOR(S)
Han, Yang; Tu, Wei-wei; Wen, Yu-gang; Li, Da-peng; Qiu, Guo-qiang; Tang, Hua-mei; Peng, Zhi-hai; Zhou, Chong-zhi
PUB. DATE
June 2013
SOURCE
Medical Oncology;Jun2013, Vol. 30 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
87820220

 

Related Articles

  • Decreased expression of Nedd4L correlates with poor prognosis in gastric cancer patient. Gao, Chengcheng; Pang, Liqun; Ren, Chengcheng; Ma, Tianheng // Medical Oncology;Sep2012, Vol. 29 Issue 3, p1733 

    The neural precursor cell expressed, developmentally down-regulated 4-like (Nedd4L) gene encodes an ubiquitin ligase that targets the epithelial sodium channel for degradation. Recent studies have demonstrated that Nedd4L plays a role in the progression of various cancers. However, the clinical...

  • Increased MMP-21 expression is associated with poor overall survival of patients with gastric cancer. Wu, Tao; Li, Yi; Lu, Jianguo; Qiao, Qing; Bao, Guoqiang; Wang, Nan; He, Xianli; Du, Xilin // Medical Oncology;Mar2013, Vol. 30 Issue 1, p1 

    Matrix metalloproteinase-21 (MMP-21) has been shown to enhance tumor invasion and metastasis ability in some solid tumors. In the present study, we investigated the expression of MMP-21 as well as its association with overall survival of gastric cancer patients. MMP-21 expression was...

  • Clinical significance of polypeptide N-acetylgalactosaminyl transferase-5 (GalNAc-T5) expression in patients with gastric cancer. He, H; Shen, Z; Zhang, H; Wang, X; Tang, Z; Xu, J; Sun, Y // British Journal of Cancer;4/15/2014, Vol. 110 Issue 8, p2021 

    Background:The family of polypeptide N-acetylgalactosaminyl transferases is responsible for the altered O-linked glycosylation occurring during the development of various cancers and their progression via altering O-glycan biosynthesis. Our studies were designed to investigate the expression and...

  • Google Goes Cancer: Improving Outcome Prediction for Cancer Patients by Network-Based Ranking of Marker Genes. Winter, Christof; Kristiansen, Glen; Kersting, Stephan; Roy, Janine; Aust, Daniela; Knösel, Thomas; Rümmele, Petra; Jahnke, Beatrix; Hentrich, Vera; Rückert, Felix; Niedergethmann, Marco; Weichert, Wilko; Bahra, Marcus; Schlitt, Hans J.; Settmacher, Utz; Friess, Helmut; Büchler, Markus; Saeger, Hans-Detlev; Schroeder, Michael; Pilarsky, Christian // PLoS Computational Biology;May2012, Vol. 8 Issue 5, p1 

    Predicting the clinical outcome of cancer patients based on the expression of marker genes in their tumors has received increasing interest in the past decade. Accurate predictors of outcome and response to therapy could be used to personalize and thereby improve therapy. However, state of the...

  • TROP2 expression as prognostic marker for gastric carcinoma. G Mühlmann // Journal of Clinical Pathology;Feb2009, Vol. 62 Issue 2, p152 

    BACKGROUND: In gastric cancer the recurrence rate is unacceptably high, even after R0 resection and (neo)adjuvant chemotherapy. Therefore, there is an urgent need for identification of predictive and/or prognostic biomarkers to select high-risk patients who might benefit from additional...

  • Mucin Expression in Gastric Cancer Reappraisal of Its Clinicopathologic and Prognostic Significance. Dae Hwan Kim; Nari Shin; Gwang Ha Kim; Geum Am Song; Tae-Yong Jeon; Dong-Heon Kim; Lauwers, Gregory Y.; Do Youn Park // Archives of Pathology & Laboratory Medicine;Aug2013, Vol. 137 Issue 8, p1047 

    Context.-The clinical validity of mucin expression in gastric cancer is debated. Whereas several reports demonstrate a correlation between mucin expression and prognosis, others deny such an association. Objective.-This survival analysis study aims to elucidate the prognostic significance of...

  • Downregulation of ALDOB is associated with poor prognosis of patients with gastric cancer. Jun He; Yi Jin; Yuan Chen; Hai-Bo Yao; Ying-Jie Xia; Ying-Yu Ma; Wei Wang; Qin-Shu Shao // OncoTargets & Therapy;Oct2016, Vol. 9, p6099 

    Objectives: To examine the expression of ALDOB in gastric cancer (GC) tissue and to reveal its potential clinicopathological and prognostic significance. Materials and methods: We screened for genes that were differentially expressed between GC and nontumor tissues using a microarray,...

  • Epidermal Growth Factor Receptor (EGFR) Expression is Associated With a Worse Prognosis in Gastric Cancer Patients Undergoing Curative Surgery. Galizia, Gennaro; Lieto, Eva; Orditura, Michele; Castellano, Paolo; la Mura, Anna; Imperatore, Vincenzo; Pinto, Margherita; Zamboli, Anna; de Vita, Ferdinando; Ferraraccio, Francesca // World Journal of Surgery;Jul2007, Vol. 31 Issue 7, p1458 

    In gastric cancer, the recurrence rate is high even after curative surgery. A relevant issue is the identification of independent prognostic factors to select high-risk patients; such features can be used as predictive factors for tailored therapies. In this study we have investigated the role...

  • Clinical significance of prognostic score based on age, tumor size, and grade in gastric cancer after gastrectomy. Lu, Jingfeng; Chen, Yi; Liu, Yanxia; Ding, Junbin; Piao, Zhenhao; Liu, Weiyan // Cancer Management & Research;Oct2018, Vol. 10, p4279 

    Background: Postoperative management and survival of gastric cancer is mainly determined by pathologic TNM stage. However, gastric cancer is a heterogeneity group, and the survival is quite different even when they are in the same TNM stage. Moreover, TNM stage system does not grasp other...

  • Stem cell factor is a novel independent prognostic biomarker for hepatocellular carcinoma after curative resection. Wang, Xiuchao; Ren, He; Zhao, Tiansuo; Chen, Jing; Sun, Wei; Sun, Yan; Ma, Weidong; Wang, Jian; Gao, Chuntao; Gao, Song; Lang, Mingxiao; Jia, Li; Hao, Jihui // Carcinogenesis;Oct2014, Vol. 35 Issue 10, p2283 

    We have independently validated SCF and CD34 as prognostic biomarkers for HCC, and report for the first time that SCF is a novel independent prognostic biomarker for patients with HCC after curative resection. Combining SCF and CD34 further improves prognostic stratification.Stem cell factor...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics